摘要
目的 探讨生长抑素联合奥美拉唑在肝硬化上消化道出血治疗与干预中的效果。方法 此次依不同治疗方式将2015年1月-2017年1月于恩泽医疗中心(集团)台州医院治疗的肝硬化上消化道出血患者80例分为对照组和观察组,对照组用奥美拉唑治疗,观察组用生长抑素+奥美拉挫治疗;记录2组患者各项实验数据,并将所获相关数据作对比分析,探讨生长抑素联合奥美拉唑在肝硬化上消化道出血治疗与干预中的效果。结果 观察组临床治疗效果优于对照组,组间比较差异有统计学意义(P〈0.05)。结论 肝硬化上消化道出血患者选择生长抑素+奥美拉唑治疗效果显著、不良反应少。
Objective To investigate the effects of somatostatin combined with omeprazole in treatment of digestive tract hemorrhage and the intervention effect in cirrhosis. Methods According to the different treatment methods will be January 2015 to January 2017 in Taizhou Hospital treatment of gastrointestinal bleeding in patients with cirrhosis 80 cases groups: control group was treated with omeprazole and omeprazole and somatostatin in the treatment of observation group; two groups were recorded in the experimental data, and the data were analyzed, the effect of somatostatin combined with omeprazole in treatment of digestive tract hemorrhage and the intervention effect in patients with liver cirrhosis. Results The observation group clinical treatment effect is better than that of control group clinical treatment groups was statistically significant the difference between (P〈 0.05). Conclusion The bleeding patients choose somatostatin omeprazole treatment effect on liver cirrhosis digestive adverse little response.
出处
《中国生化药物杂志》
CAS
2017年第8期117-118,121,共3页
Chinese Journal of Biochemical Pharmaceutics
关键词
生长抑素
奥美拉唑
肝硬化
上消化道出血
护理干预
somatostatin
Omeprazole
liver cirrhosis
upper gastrointestinal bleeding
nursing intervention